CARD10 and hepatocellular carcinoma: These results suggest that the regulation of CARMA3 contributes to chemoresistance in HCC through its effects on oxidative stress and survival pathways, thereby providing a mechanistic explanation for the role of CARMA3 in mediating sorafenib resistance and its reversal by triptolide treatment.